Vivek Singam

Vivek Singam

Auto-generated profile, based on publicly available information

Vivek Singam

Department of Internal Medicine Weiss Memorial Hospital Chicago IL USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
PVParas P. Vakharia
Paras P. Vakharia
RCRishi Chopra
Rishi Chopra
RSRyan Sacotte
Ryan Sacotte
KPKevin R. Patel
Kevin R. Patel
VSVivek Singam
Vivek Singam
JSJonathan Silverberg
Jonathan Silverberg

1 June 2019 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
HLHarrison H. Lee
Harrison H. Lee
KPKevin R. Patel
Kevin R. Patel
VSVivek Singam
Vivek Singam
SRSupriya Rastogi
Supriya Rastogi
JSJonathan Silverberg
Jonathan Silverberg

1 February 2019 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
KPKevin R. Patel
Kevin R. Patel
SISupriya Immaneni
Supriya Immaneni
VSVivek Singam
Vivek Singam
SRSupriya Rastogi
Supriya Rastogi
JSJonathan Silverberg
Jonathan Silverberg

1 September 2020 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
KPKevin R. Patel
Kevin R. Patel
HLHarrison H. Lee
Harrison H. Lee
SRSupriya Rastogi
Supriya Rastogi
PVParas P. Vakharia
Paras P. Vakharia
THTammy Hua
Tammy Hua
JSJonathan Silverberg
Jonathan Silverberg

1 October 2018 in Dermatitis®
Verified
Journal Article
Closed access
JLJennifer C. Bs Li
Jennifer C. Bs Li
AFAnna Fishbein
Anna Fishbein
VSVivek Bla Singam
Vivek Bla Singam
KPKevin R. Bs Patel
Kevin R. Bs Patel
PZPhyllis C. Zee
Phyllis C. Zee
JSJonathan Silverberg
Jonathan Silverberg
Background: Little is known about the impact of sleep disturbances (SD) or sleep-related impairment (SRI) in adults with AD or their relationship with severity of AD and itch and other predictors. Objective: The aim of this study was to determine the relationship between AD severity, SD, and SRI. Methods: We conducted a prospective online questionnaire-based study of 287 adults with AD, including assessment of AD severity by Patient-Oriented Eczema Measure, self-reported global AD severity, Self-Assessed Eczema Area and Severity Index and visual analog scale–itch, Patient-Reported Outcome Measurement Information System SD and SRI individual items, and T scores. Results: Adults with AD commonly endorsed all SD and SRI symptoms examined; only 58 (21.8%) reported having good or very good sleep quality in the past week. However, only a minority of adults with AD endorsed a more profound impact from these individual aspects of SD and SRI in the past week or Patient-Reported Outcome Measurement Information System T scores greater than 55. In particular, SD and SRI were associated with severe or very severe AD (Patient-Oriented Eczema Measure, self-reported severity, visual analog scale–itch, and/or Self-Assessed Eczema Area and Severity Index). Sleep-related impairment was also associated with comorbid hay fever and/or anxiety. Conclusions: This study suggests that SD and SRI are common in adults with AD, particularly those with severe diseases. Sleep disturbances and SRI should be considered when assessing burden of AD and therapeutic decisions.

1 February 2021 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
NRNanna Ravnborg
Nanna Ravnborg
DADanni Ambikaibalan
Danni Ambikaibalan
GAGaurav Agnihotri
Gaurav Agnihotri
SPShmuel Price
Shmuel Price
SRSupriya Rastogi
Supriya Rastogi
JTJacob P. Thyssen
Jacob P. Thyssen